Literature DB >> 28032952

Clinical outcome of salvage neck dissections in head and neck cancer in relation to initial treatment, extent of surgery and patient factors.

K van den Bovenkamp1, M G Noordhuis1, S F Oosting2, B F A M van der Laan1, J L Roodenburg3, H P Bijl4, G B Halmos1, B E C Plaat1.   

Abstract

OBJECTIVE: Salvage surgery has a higher complication rate compared to primary surgical treatment. We evaluated clinical outcome of salvage neck dissections in relation to initial treatment modality, extent of surgery and patient-related factors.
DESIGN: Single institution consecutive case series.
SETTING: Tertiary Head and Neck Cancer Centre. PARTICIPANTS: In all, 87 patients with head and neck squamous cell carcinoma, who underwent salvage neck dissection after initial radiotherapy (n = 30), radiotherapy with carboplatin/5-fluorouracil (n = 43) or radiotherapy with cetuximab (n = 14). MAIN OUTCOME MEASURES: Incidence of complications, disease-specific survival.
RESULTS: Complications occurred in 28% of the patients. Multivariate analysis identified extent of neck dissection as the only independent predictor of surgical complications (P = 0.010). Surgical complication rate was 16% after radiotherapy with systemic treatment, and 47% after radiotherapy alone (P = 0.171). The 5-year disease-specific survival was 55%, independent of complications, initial treatment, extent of surgery and patient-related factors.
CONCLUSION: The only predictor for surgical complications was extent of surgery. Survival was not influenced by complications.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28032952     DOI: 10.1111/coa.12818

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  7 in total

1.  Surgical rescue for persistent head and neck cancer after first-line treatment.

Authors:  Teresa Bernadette Steinbichler; L Golm; D Dejaco; D Riedl; B Kofler; C Url; D Wolfram; H Riechelmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-25       Impact factor: 2.503

2.  Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer.

Authors:  Jeroen E van Schaik; Saskia H Hanemaaijer; György B Halmos; Max J H Witjes; Bernard F A M van der Laan; Bert van der Vegt; Boudewijn E C Plaat
Journal:  Otolaryngol Head Neck Surg       Date:  2020-06-30       Impact factor: 3.497

Review 3.  Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.

Authors:  Jameel Muzaffar; Shahla Bari; Kedar Kirtane; Christine H Chung
Journal:  Cancers (Basel)       Date:  2021-01-18       Impact factor: 6.639

4.  A comparison of the Thunderbeat and standard electrocautery devices in head and neck surgery: a prospective randomized controlled trial.

Authors:  N C Kuipers; B J de Kleijn; J Wedman; B F A M van der Laan; B E C Plaat; G B Halmos
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-19       Impact factor: 2.503

5.  Elective neck dissection (END) and cN0 hard palate and upper gingival cancers: A National Cancer Database analysis of factors predictive of END and impact on survival.

Authors:  Adetokunbo Obayemi; Jennifer R Cracchiolo; Jocelyn C Migliacci; Qasim Husain; Rahmatullah Rahmati; Benjamin R Roman; Marc A Cohen
Journal:  J Surg Oncol       Date:  2019-09-23       Impact factor: 3.454

6.  Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma.

Authors:  Gerhard Frank Huber
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

7.  Surgical nodal management in hypopharyngeal and laryngeal cancer.

Authors:  M C Ketterer; L A Lemus Moraga; U Beitinger; J Pfeiffer; A Knopf; C Becker
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-11       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.